Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03192163 · ClinicalTrials.gov registry record
Cultural Differences in Treatment Preferences and Perceptions of Acne
A clinical trial of Acne Vulgaris, sponsored by Northwestern University.
- Completed
- Registry status
- 217
- Enrollment target
- 1
- Study location
NCT03192163: Completed study of Acne Vulgaris, sponsored by Northwestern University.
NCT03192163 is a study of Acne Vulgaris that has completed, run by Northwestern University. The registered enrollment target is 217 participants, below the 272-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03192163, a study of Acne Vulgaris, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use a survey to examine relationships between culture, race, and ethnicity with treatment preferences and perceptions for acne vulgaris.
Primary Outcome
percentage of income individual is willing to pay to use a treatment that improves his or her acne
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2015-06 |
| Est. Completion | 2018-02 |
What the finished NCT03192163 record still lists
NCT03192163 is an observational study that tracks outcomes without assigning an intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (20% lower).
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT03192163 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03192163 about?
NCT03192163 is a clinical study titled "Cultural Differences in Treatment Preferences and Perceptions of Acne". This study will use a survey to examine relationships between culture, race, and ethnicity with treatment preferences and perceptions for acne vulgaris.
What is the current status of trial NCT03192163?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2015-06. Estimated completion is 2018-02.
What conditions does trial NCT03192163 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT03192163?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT03192163?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03192163 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03192163's enrollment target sits among peer trials
217 27th of 67 higher than 41 of 67 other Acne Vulgaris trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne Vulgaris trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Weekly Isotretinoin vs Tetracycline for Moderate Acne
RECRUITING · Early Phase 1
-
Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
RECRUITING · Phase 1
-
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
ACTIVE NOT RECRUITING · Phase 2
-
Laser Treatment of Moderate to Severe Acne Vulgaris
ACTIVE NOT RECRUITING · NA
-
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
ACTIVE NOT RECRUITING · Phase 4
-
A Post Market Device Study for the Treatment of Acne
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia